P 26
Latest Information Update: 11 Feb 1998
At a glance
- Originator Phytopharm
- Class Antidementias; Neuroprotectants
- Mechanism of Action Acetylcholinesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 11 Feb 1998 Discontinued-Preclinical for Alzheimer's disease in United Kingdom (Unknown route)
- 27 Feb 1997 New profile
- 27 Feb 1997 Preclinical development for Alzheimer's disease in United Kingdom (Unknown route)